Ipatasertib (GDC-0068) is an Orally Active Pan-Akt Inhibitor for Cancer Research
Colon cancer is a common occurrence in a malignant tumor of the digestive tract with the high mortality rate, but low survival rate. However, colorectal cancer is the fourth most…